Mineralocorticoid receptor antagonists, a class beyond spironolactone — Focus on the special pharmacologic properties of eplerenone - International Journal of Cardiology
PHA 824
Potassium sparing diuretics – Mechanism and actions
Frontiers | The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer | Oncology
potassium_sparing_diuretics [TUSOM | Pharmwiki]
New Acne Therapies and Updates on Use of Spironolactone and Isotretinoin: A Narrative Review
Blocking mineralocorticoid receptor with spironolactone may have a wide range of therapeutic actions in severe COVID-19 disease | Critical Care | Full Text
Pharmaceuticals | Free Full-Text | COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection | HTML
Diuretics II
Biomolecules | Free Full-Text | Spironolactone and XPB: An Old Drug with a New Molecular Target | HTML
PHA 824
Chapter 41 Diuretics ppt video online download
Management of cirrhotic ascites: Physiological basis of diuretic action - European Journal of Internal Medicine
Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction | Journal of the American Heart Association
Aldactone (Spironolactone) for Hormonal Acne
Spironolactone - Wikipedia
Aldactone Mechanism of Action | MIMS Philippines
Deresuscitation: Dominating the Diuresis - EMCrit Project
JaypeeDigital | eBook Reader
Schematic of sites of action and mechanism of ion channel blockade by... | Download Scientific Diagram
PHA 824
Diuretics Part 2
Diuretics the role of different portions of the nephron in ion exchange; the sites of action and pharmacology of diuretics; the therapeutic applications. - ppt video online download